Search by Drug Name or NDC

    NDC 67457-0469-10 Oxaliplatin 5 mg/mL Details

    Oxaliplatin 5 mg/mL

    Oxaliplatin is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Mylan Institutional LLC. The primary component is OXALIPLATIN.

    Product Information

    NDC 67457-0469
    Product ID 67457-469_e54fedad-8020-4470-af8f-37f113470b6a
    Associated GPIs 21100028002025
    GCN Sequence Number 059162
    GCN Sequence Number Description oxaliplatin VIAL 50 MG/10ML INTRAVEN
    HIC3 V1A
    HIC3 Description ANTINEOPLASTIC - ALKYLATING AGENTS
    GCN 24699
    HICL Sequence Number 016687
    HICL Sequence Number Description OXALIPLATIN
    Brand/Generic Generic
    Proprietary Name Oxaliplatin
    Proprietary Name Suffix n/a
    Non-Proprietary Name Oxaliplatin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 5
    Active Ingredient Units mg/mL
    Substance Name OXALIPLATIN
    Labeler Name Mylan Institutional LLC
    Pharmaceutical Class Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA091358
    Listing Certified Through 2024-12-31

    Package

    NDC 67457-0469-10 (67457046910)

    NDC Package Code 67457-469-10
    Billing NDC 67457046910
    Package 1 VIAL in 1 CARTON (67457-469-10) / 10 mL in 1 VIAL
    Marketing Start Date 2014-08-25
    NDC Exclude Flag N
    Pricing Information N/A